Clinical Trial Update: A Trial of Metformin in Individuals With Fragile X Syndrome (Met) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin in individuals with Fragile X syndrome has completed; this entry provides a status update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Alberta | Conditions: Fragile X Syndrome, Fragile X Mental Retardation Syndrome | Phase 2 | Status: COMPLETED